- Q1 8 %88.9
- Q2 0 %0.0
- Q3 1 %11.1
- Q4 0 %0.0
Academician
DENİZ LENGERLİ
Doktor Öğretim Üyesi
Gazi Üniversitesi Eczacılık Fakültesi Eczacılık Meslek Bilimleri Bölümü
- Synthesis and biological activity3
- Eicosanoids and Hypertension Pharmacology2
- Microtubule and mitosis dynamics2
- Cancer-related Molecular Pathways2
- Click Chemistry and Applications2
- Crystal structures of chemical compounds1
- Synthesis and Reactions of Organic Compounds1
- Biochemical and Molecular Research1
- DNA Repair Mechanisms1
- Protein Tyrosine Phosphatases1
- Pharmacogenetics and Drug Metabolism1
- Free Radicals and Antioxidants1
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Farmasotik Kimya
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 8 + YÖKSİS · co-author record: 1- i10-index
- 3
- Total citations
- 217 Top 26% in Türkiye
- Per article
- 24.1
- FWCI
- 2.79 1.00 = world average
- World top 1%
- 1
- World top 10%
- 3
Most cited articles
- The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
- Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification
- A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included. 1 articles (32 citations) tagged with this academic’s YÖK author id in co-authors’ YÖKSİS records count only towards citations, h-index and i10; article counts, percentiles and rankings use their own YÖKSİS list.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #20,574/ 39,745 top 51.8% At university #627/ 856Score 9.6 journal 8.6 · OA add 1
- Article rank24,906/39,745
- Scopus rank20,984/39,745
- WoS rank20,686/39,745
- YÖKSİS9
- Scopus9
- WoS9
-
Side field Farmasotik KimyaPoints rank #103/ 206 top 50.0% At university #13/ 19Score 9.6 journal 8.6 · OA add 1
- Article rank119/206
- Scopus rank109/206
- WoS rank105/206
- YÖKSİS9
- Scopus9
- WoS9
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 36
- With an akaturk profile
- 15
- Turkish institutions
- 6
- Co-authored works
- %100
Academic co-authors 15
- ERDEN BANOĞLU Profesör · Gazi Üniversitesi same university 9
- BURCU ÇALIŞKAN Profesör · Gazi Üniversitesi same university 7
- KÜBRA ÇALIŞKAN Doktor Öğretim Üyesi · Gazi Üniversitesi same university 5
- ÖZGE AKBULUT ÇALIŞKAN Doktor Öğretim Üyesi · Başkent Üniversitesi 3
- AYŞEGÜL ÜNER Profesör · Hacettepe Üniversitesi 2
- MERAL ÜNER Doktor Öğretim Üyesi · Hacettepe Üniversitesi 2
- SERCAN AKSOY Profesör · Hacettepe Üniversitesi 2
- ABDULLAH AYDIN Profesör · Kastamonu Üniversitesi 1
- BEYZANUR KOÇ Araştırma Görevlisi · Gazi Üniversitesi same university 1
- ECE AKHAN GÜZELCAN Öğretim Görevlisi (uygulamalı Birim) · Hacettepe Üniversitesi 1
Show all (15)
- ESRA NALBAT Araştırma Görevlisi · Orta Doğu Teknik Üniversitesi 1
- NEFİSE ÖZÇELİK Profesör · Aksaray Üniversitesi 1
- NUR BANU BAL Doçent · Gazi Üniversitesi same university 1
- SEZEN GÜNTEKİN ERGÜN Öğretim Görevlisi (uygulamalı Birim) · Hacettepe Üniversitesi 1
- YAHYA NURAL Profesör · Mersin Üniversitesi 1
National collaboration 6 institutions
Within own university9 joint works · Gazi Üniversitesi
- Başkent Üniversitesi 3 works · 1 academics
- Hacettepe Üniversitesi 3 works · 5 academics
- Aksaray Üniversitesi 1 works · 1 academics
- Kastamonu Üniversitesi 1 works · 1 academics
- Mersin Üniversitesi 1 works · 1 academics
- Orta Doğu Teknik Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 21
ÖZGÜR ŞAHİN 4Özge Saatci 4Elizabeth C. O’Quinn 2METİN ÇETİN 2Martin J. Romeo 2Oliver Werz 2Paul M Jordan 2SÜMEYYE TURANLI 2Arroj BakhtAynur IsikChaemin LimElif DumanMEHMET AKKURTMESUT MUYANOzge AkbulutPhilipp DahlkeRENGÜL ATALAYSridhar VempatiUrartu OS SekerVITALI SIKIRZYHTSKIVitali Sikirzhytski
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.
Index quartiles
?- Q1 7 %77.8
- Q2 1 %11.1
- Q3 0 %0.0
- Q4 1 %11.1
Other counts
Scopus (SJR)
- Excluding abstracts 8 Q1 7 Q3 1
- YÖKSİS rows 9
WoS (JCR)
- Excluding abstracts 8 Q1 6 Q2 1 Q4 1
- YÖKSİS rows 9
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
8 journals
Narrow down
Article list
- 2025 Potent soluble epoxide hydrolase inhibitors based on thiazole-5-carboxamide structure with imidazolidinone moiety as a secondary pharmacophore YÖKSİS SJR Q1 JCR Q1 OpenAlex 72.6%
- 2025 Phenyl-benzyl-ureas with pyridazinone motif: Potent soluble epoxide hydrolase inhibitors with enhanced pharmacokinetics and efficacy in a paclitaxel-induced neuropathic pain model YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 91.9%
- 2025 Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy YÖKSİS SJR Q1 JCR Q1 OpenAlex 66.4%
- 2024 Abstract PO4-24-04: Identifying the interactome of TACC3, a major driver in aggressive cancer cells with centrosome amplification YÖKSİS SJR Q1 JCR Q1
- 2023 Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.5%
- 2022 Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity YÖKSİS SJR Q1 JCR Q2 OpenAlex 63.5%
- 2022 The 1,2,3-triazole 'all-in-one' ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.2%
- 2021 Crystal structure and Hirshfeld surface analysis of 4-(4-chlorophenyl)-5-methyl-3-{4-[(2-methylphenyl)methoxy]phenyl}-1,2-oxazole YÖKSİS SJR Q3 JCR Q4 OpenAlex 35.6%
- 2020 A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate YÖKSİS SJR Q1 JCR Q1